Electrical stimulation of the cochlea for treatment of chronic disabling tinnitus: an open-label trial towards the development of an implantable device

John P Marinelli, C Lane Anzalone, Christoph M Prummer, Gayla L Poling, Jeffrey P Staab, Nicole M Tombers, Christine M Lohse, Matthew L Carlson, John P Marinelli, C Lane Anzalone, Christoph M Prummer, Gayla L Poling, Jeffrey P Staab, Nicole M Tombers, Christine M Lohse, Matthew L Carlson

Abstract

Background: Chronic tinnitus affects millions of people globally and constitutes the most commonly compensated disability among military service members in the United States. Existing treatment options largely surround helping patients cope with their disease as opposed to directly suppressing tinnitus perception. The current study investigated the efficacy of electrical stimulation of the cochlea on chronic disabling tinnitus.

Methods: In this single-arm, open-label clinical trial, 22 adult subjects with severe-range asymmetric or unilateral non-pulsatile tinnitus underwent electrical stimulation of the cochlea through use of an extra-cochlear electrode positioned on the cochlear promontory. Each subject underwent 3 stimulation treatments over 3 weeks at 7-day intervals. Tinnitus severity was determined by Tinnitus Handicap Inventory (THI), Tinnitus Functional Index (TFI), and Tinnitus Visual Analog Scale (VAS). Inclusion criteria required subjects have no worse than moderate sensorineural hearing loss determined by pre-enrollment audiometric testing. The primary outcome was nadir post-treatment THI scores, obtained at seven timepoints following electrical stimulation, with clinically significant improvement defined as a decrease of ≥ 7.

Results: All 22 (100%) subjects experienced clinically significant improvement in the THI during the study period with a mean decrease in scores of - 31 (95% CI - 38 to - 25) from a baseline of 48. Twenty (91%) experienced clinically significant improvement detectable on at least two of the three tinnitus survey instruments and 17 (77%) experienced clinically significant improvement detectable on all three survey instruments (i.e., THI, TFI, and VAS). Eight (36%) subjects reported either complete (THI of 0; n = 3) or near-complete (THI 1-4; n = 5) suppression of their tinnitus following a stimulation session. Thirteen (59%) subjects reported a nadir following stimulation at or below the threshold for "no or slight handicap" on the THI (≤ 16). No adverse events were observed.

Conclusions: These findings establish the foundation for the development of an extra-cochlear implantable device that delivers electrical stimulation to the cochlea for the treatment of disabling tinnitus. For patients considering device implantation, trans-tympanic cochlear promontory stimulation can facilitate patient selection. Trial Registration ClinicalTrials.gov Identifier: NCT03759834. URL: https://ichgcp.net/clinical-trials-registry/NCT03759834.

Keywords: Clinical trial; Cochlear implant; Electrical stimulation; Implantable device; Promontory stimulation; Tinnitus; Treatment.

Conflict of interest statement

M.L.C. reports holding pending patents 62/346,306, PCT/US2017/035617, and WO2017213978A1 on devices and methods for treating tinnitus with the use of electrical stimulation. No other authors have relevant conflicts of interest to disclose. The views expressed herein are those of the authors and do not reflect the official policy or position of Mayo Clinic, Brooke Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of the Air Force, or the Department of Defense or the U.S. Government.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Trans-tympanic electrical stimulation of the cochlea. A Equipment used for promontory stimulation, including the Cochlear Nucleus Promontory Stimulator Z10012® (Cochlear Corporation, Melbourne, Australia). B Otomicroscopic view of the left tympanic membrane. C, D Surgeon placing the trans-tympanic monopolar needle electrode on the promontory. E Stabilized electrode in left ear. F Typical location of the needle electrode on the promontory of the cochlea is shown (white arrowhead) through a facial-recess approach commonly used for cochlear implantation[22]. G, H oscilloscope recording of promontory stimulation output demonstrating charge-balanced square biphasic pulse waveforms

References

    1. Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline: tinnitus. Otolaryngol Head Neck Surg. 2014;151:S1–S40. doi: 10.1177/0194599814545325.
    1. Henry JA, Reavis KM, Griest SE, et al. Tinnitus: an epidemiologic perspective. Otolaryngol Clin North Am. 2020;53:481–499. doi: 10.1016/j.otc.2020.03.002.
    1. Baguley D, McFerran D, Hall D. Tinnitus. Lancet. 2013;382:1600–1607. doi: 10.1016/S0140-6736(13)60142-7.
    1. van Zon A, Smulders YE, Ramakers GG, et al. Effect of unilateral and simultaneous bilateral cochlear implantation on tinnitus: a prospective study. Laryngoscope. 2016;126:956–961. doi: 10.1002/lary.25493.
    1. Peter N, Liyanage N, Pfiffner F, Huber A, Kleinjung T. The influence of cochlear implantation on tinnitus in patients with single-sided deafness: a systematic review. Otolaryngol Head Neck Surg. 2019;161:576–588. doi: 10.1177/0194599819846084.
    1. Holder JT, O’Connell B, Hedley-Williams A, Wanna G. Cochlear implantation for single-sided deafness and tinnitus suppression. Am J Otolaryngol. 2017;38:226–229. doi: 10.1016/j.amjoto.2017.01.020.
    1. Deep NL, Spitzer ER, Shapiro WH, Waltzman SB, Roland JT, Jr, Friedmann DR. Cochlear implantation in adults with single-sided deafness: outcomes and device use. Otol Neurotol. 2021;42:414–423. doi: 10.1097/MAO.0000000000002955.
    1. Mallen JR, Chiu J, Marquis H, et al. Quantifying tinnitus suppression in cochlear implantation using tinnitus interval-limited tracking. Laryngoscope. 2020;130:2047–2052. doi: 10.1002/lary.28414.
    1. Mertens G, De Bodt M, Van de Heyning P. Cochlear implantation as a long-term treatment for ipsilateral incapacitating tinnitus in subjects with unilateral hearing loss up to 10 years. Hear Res. 2016;331:1–6. doi: 10.1016/j.heares.2015.09.016.
    1. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1996;122:143–148. doi: 10.1001/archotol.1996.01890140029007.
    1. Zeman F, Koller M, Figueiredo R, et al. Tinnitus Handicap Inventory for evaluating treatment effects: which changes are clinically relevant? Otolaryngol Head Neck Surg. 2011;145:282–287. doi: 10.1177/0194599811403882.
    1. Meikle MB, Henry JA, Griest SE, et al. The Tinnitus Functional Index: development of a new clinical measure for chronic, intrusive tinnitus. Ear Hear. 2012;33:153–176. doi: 10.1097/AUD.0b013e31822f67c0.
    1. Adamchic I, Langguth B, Hauptmann C, Tass PA. Psychometric evaluation of Visual Analog Scale for the assessment of chronic tinnitus. Am J Audiol. 2012;21:215–225. doi: 10.1044/1059-0889(2012/12-0010).
    1. Angara P, Tsang DC, Hoffer ME, Snapp HA. Self-perceived hearing status creates an unrealized barrier to hearing healthcare utilization. Laryngoscope. 2021;131:E289–E295. doi: 10.1002/lary.28604.
    1. Limviriyakul S, Supavanich W. The validity and reliability of Tinnitus Handicap Inventory Thai version. J Med Assoc Thai. 2012;95:1433–1440.
    1. Barake R, Rizk SA, Ziade G, Zaytoun G, Bassim M. Adaptation of the Arabic Version of the Tinnitus Handicap Inventory. Otolaryngol Head Neck Surg. 2016;154:508–512. doi: 10.1177/0194599815621551.
    1. Tobias CA, Llanes EG, Chiong C. Validity of a Filipino translation of the Tinnitus Handicap Inventory. Int Tinnitus J. 2012;17:64–69.
    1. Monzani D, Genovese E, Marrara A, et al. Validity of the Italian adaptation of the Tinnitus Handicap Inventory; focus on quality of life and psychological distress in tinnitus-sufferers. Acta Otorhinolaryngol Ital. 2008;28:126–134.
    1. Zachariae R, Mirz F, Johansen LV, Andersen SE, Bjerring P, Pedersen CB. Reliability and validity of a Danish adaptation of the Tinnitus Handicap Inventory. Scand Audiol. 2000;29:37–43. doi: 10.1080/010503900424589.
    1. Engineer ND, Rosellini WM, Tyler RS. Willingness to accept and pay for implantable tinnitus treatments: a survey. Neuromodulation. 2013;16:154–162. doi: 10.1111/j.1525-1403.2012.00487.x.
    1. Roland JT, Jr, Gantz BJ, Waltzman SB, Parkinson AJ. Long-term outcomes of cochlear implantation in patients with high-frequency hearing loss. Laryngoscope. 2018;128:1939–1945. doi: 10.1002/lary.27073.
    1. Carlson ML. Cochlear implantation in adults. N Engl J Med. 2020;382:1531–1542. doi: 10.1056/NEJMra1904407.
    1. Leake PA, Snyder RL, Hradek GT, Rebscher SJ. Consequences of chronic extracochlear electrical stimulation in neonatally deafened cats. Hear Res. 1995;82:65–80. doi: 10.1016/0378-5955(94)00167-O.
    1. Ni D, Shepherd RK, Seldon HL, Xu SA, Clark GM, Millard RE. Cochlear pathology following chronic electrical stimulation of the auditory nerve. I: Normal hearing kittens. Hear Res. 1992;62:63–81. doi: 10.1016/0378-5955(92)90203-Y.

Source: PubMed

3
Tilaa